San Francisco, CA, United States of America

Jackson Leong

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Gigagen, Inc.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jackson Leong. Retrieved from https://idiyas.com/inventor/jackson-leong-7ap5kvtf

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jackson Leong: Innovator in Recombinant Polyclonal Proteins

Introduction

Jackson Leong is a notable inventor based in San Francisco, CA. He has made significant contributions to the field of biotechnology, particularly in the development of recombinant polyclonal proteins. His work has implications for various applications in medicine and research.

Latest Patents

Leong holds a patent for "Recombinant polyclonal proteins and methods of use thereof." This patent includes compositions comprising recombinant polyclonal proteins (RPPs) derived from mammalian plasma cells and plasmablasts. The methods of using these RPPs are also detailed in the patent, showcasing their potential utility in various scientific and medical fields. He has 1 patent to his name.

Career Highlights

Jackson Leong is currently employed at Gigagen, Inc., a company focused on advancing the field of immunology through innovative technologies. His role at Gigagen allows him to work on cutting-edge research and development projects that aim to improve health outcomes.

Collaborations

Leong collaborates with talented individuals in his field, including David Scott Johnson and Adam Shultz Adler. These partnerships enhance the research and development efforts at Gigagen, fostering an environment of innovation and creativity.

Conclusion

Jackson Leong is a prominent figure in the biotechnology sector, with a focus on recombinant polyclonal proteins. His contributions through patents and collaborations highlight his commitment to advancing scientific knowledge and improving health solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…